CL-316243
CAS: 151126-84-0
Ref. 3D-BGA12684
1mg | A consultar | ||
2mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar |
Información del producto
- 1,3-Benzodioxole-2,2-dicarboxylic acid, 5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-, disodium salt
- 1,3-Benzodioxole-2,2-dicarboxylic acid, 5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-, sodium salt (1:2)
- 1,3-Benzodioxole-2,2-dicarboxylic acid, 5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-, disodium salt, [R-(R*,R*)]-
- 5-[(2R)-2-[[(2R)-2-(3-Chlorophenyl)-2-Hydroxyethyl]Amino]Propyl]-1,3-Benzodioxole-2,2-Dicarboxylic Acid Disodium Salt
- 5-[(2R)-2-[[(2R)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylicaciddisodiumsalt
- Cl 316,243
- Cl 316243 Disodium
- Cl 316243 Disodium Salt
- Hp 186
- Sodium 5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (2:1)
- Ver más sinónimos
CL-316243 is a 2-adrenergic receptor antagonist that is used to treat bowel diseases. CL-316243 binds to the 2-adrenergic receptors in the adipose tissue, which inhibits lipolysis and energy metabolism in adipose cells. This drug also inhibits the cyclase activity of adenosine 3’,5’-cyclic monophosphate (cAMP) and cGMP, which are important mediators of energy metabolism. CL-316243 has been shown to be effective in vitro against human adipocytes and may have potential as a pharmacological treatment for obesity and congestive heart failure.
Propiedades químicas
Consulta técnica sobre: 3D-BGA12684 CL-316243
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.